HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- A sluggish march toward cure for pancreatic cancer
-
- FDA approves 3-D mammography system
- FDA approves first treatment for Factor XIII deficiency
- FOLFOX4 outperformed doxorubicin in advanced hepatocellular carcinoma
- Study of zibotentan monotherapy in nonmetastatic prostate cancer halted
- Paroxysmal nocturnal hemoglobinuria: a rare disorder Amit Mehta, MD
- Residents can learn with fewer supervision training guidelines
- Blood donations go through five layers of safety
- Public health institution funding for drug development could be in danger
-
- What is the value of PET/CT for treatment response assessment in lymphoma? Munir Ghesani, MD, FACNM; Sumit Talwar, MD; Kevin Becker, MD
- Anti-estrogen therapy associated with reduced risk for death from lung cancer
- Axillary node dissection may not improve breast cancer outcomes
- For-profit hospice patients stayed longer, required less-skilled care
- Genetic pathway may predict prostate cancer progression, metastasis
- Glioma risk may be inversely related to atopic conditions
- Kyphoplasty appears effective in treatment of vertebral compression fractures in patients with cancer
- miR-200 family microRNAs involved in ovarian cancer metastasis
-
- Native American ancestry may be linked to higher risk for ALL relapse
- Oral bisphosphonates associated with reduction in risk for colorectal cancer
- Paternal history of cancer may be linked to congenital abnormalities
- Tumor-derived Jagged1 associated with breast cancer bone metastases
- Bicalutamide during and after radiation shows promise for post-radical prostatectomy
- Dutasteride may increase adherence to active surveillance in early stage prostate cancer
- Higher baseline PSA may be linked to increased prostate cancer risk
- Intermittent androgen suppression may be noninferior to continuous androgen deprivation
-
- More time may be required to reach expert level in robotic prostate surgery
- Managing fatigue at the end of life Maria Rueda-Lara, MD